---
title: "Altimmune 公司將在2025年8月12日發佈 2025 年第二季度財務報告，並提供業務更新"
description: "馬里蘭州蓋瑟斯堡，2025 年 8 月 5 日（GLOBE NEWSWIRE）-- Altimmune, Inc.（ALT），一家處於臨牀後期的生物製藥公司，今天宣佈將於 2025 年 8 月 12 日（星期二）公佈其 2025 年第二季度財務業績"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/251640052.md"
published_at: "2025-08-05T12:09:48.000Z"
---

# Altimmune 公司將在2025年8月12日發佈 2025 年第二季度財務報告，並提供業務更新

> 馬里蘭州蓋瑟斯堡，2025 年 8 月 5 日（GLOBE NEWSWIRE）-- Altimmune, Inc.（ALT），一家處於臨牀後期的生物製藥公司，今天宣佈將於 2025 年 8 月 12 日（星期二）公佈其 2025 年第二季度財務業績

GAITHERSBURG, Md., Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Altimmune, Inc. ALT, a late clinical-stage biopharmaceutical company, today announced that it will report its second quarter 2025 financial results on Tuesday, August 12, 2025.

### Related Stocks

- [ALT.US - Altimmune](https://longbridge.com/zh-HK/quote/ALT.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Altimmune Director Wayne Pisano Acquires Common Shares | Wayne Pisano, Director at Altimmune Inc., has acquired common shares of the company. The full filing is available throug | [Link](https://longbridge.com/zh-HK/news/272122963.md) |
| Altimmune Inc. Director Catherine A. Sohn Reports Acquisition of Common Shares | Catherine A. Sohn, Director at Altimmune Inc., has reported the acquisition of common shares of the company. The full fi | [Link](https://longbridge.com/zh-HK/news/271563101.md) |
| Altimmune Earns FDA Breakthrough Therapy Designation for Pemvidutide in MASH | Altimmune Inc. has received FDA Breakthrough Therapy Designation for pemvidutide, a dual receptor agonist for treating m | [Link](https://longbridge.com/zh-HK/news/271512829.md) |
| Altimmune Director Diane Jorkasky Acquires Common Shares | Diane Jorkasky, a Director at Altimmune Inc., has acquired common shares of the company. The full filing is available th | [Link](https://longbridge.com/zh-HK/news/271030324.md) |
| Altimmune Director John Gill Reports Acquisition of Common Shares | John Gill, Director at Altimmune Inc., has acquired common shares of the company. This event was reported through a fili | [Link](https://longbridge.com/zh-HK/news/270655085.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。
